241 related articles for article (PubMed ID: 12798696)
1. Neoplastic change of squamo-columnar junction in uterine cervix and vaginal epithelium by exogenous estrogen in hpv-18 URR E6/E7 transgenic mice.
Park JS; Rhyu JW; Kim CJ; Kim HS; Lee SY; Kwon YI; Namkoong SE; Sin HS; Um SJ
Gynecol Oncol; 2003 Jun; 89(3):360-8. PubMed ID: 12798696
[TBL] [Abstract][Full Text] [Related]
2. Cervical/vaginal dysplasias of transgenic mice harbouring human papillomavirus type 16 E6-E7 genes.
Sasagawa T; Kondoh G; Inoue M; Yutsudo M; Hakura A
J Gen Virol; 1994 Nov; 75 ( Pt 11)():3057-65. PubMed ID: 7964615
[TBL] [Abstract][Full Text] [Related]
3. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
[TBL] [Abstract][Full Text] [Related]
4. Regulation of cell growth and HPV genes by exogenous estrogen in cervical cancer cells.
Kim CJ; Um SJ; Kim TY; Kim EJ; Park TC; Kim SJ; Namkoong SE; Park JS
Int J Gynecol Cancer; 2000 Mar; 10(2):157-164. PubMed ID: 11240668
[TBL] [Abstract][Full Text] [Related]
5. Analysis of mutations in the URR and E6/E7 oncogenes of HPV 16 cervical cancer isolates from central China.
Stephen AL; Thompson CH; Tattersall MH; Cossart YE; Rose BR
Int J Cancer; 2000 Jun; 86(5):695-701. PubMed ID: 10797293
[TBL] [Abstract][Full Text] [Related]
6. Activation of human papillomavirus type 18 E6-E7 oncogene expression by transcription factor Sp1.
Hoppe-Seyler F; Butz K
Nucleic Acids Res; 1992 Dec; 20(24):6701-6. PubMed ID: 1336181
[TBL] [Abstract][Full Text] [Related]
7. The human papillomavirus E6 oncogene dysregulates the cell cycle and contributes to cervical carcinogenesis through two independent activities.
Shai A; Brake T; Somoza C; Lambert PF
Cancer Res; 2007 Feb; 67(4):1626-35. PubMed ID: 17308103
[TBL] [Abstract][Full Text] [Related]
8. E6 and E7 expression from the HPV 18 LCR: development of genital hyperplasia and neoplasia in transgenic mice.
Comerford SA; Maika SD; Laimins LA; Messing A; Elsässer HP; Hammer RE
Oncogene; 1995 Feb; 10(3):587-97. PubMed ID: 7845684
[TBL] [Abstract][Full Text] [Related]
9. Abrogation of IRF-1 response by high-risk HPV E7 protein in vivo.
Um SJ; Rhyu JW; Kim EJ; Jeon KC; Hwang ES; Park JS
Cancer Lett; 2002 May; 179(2):205-12. PubMed ID: 11888675
[TBL] [Abstract][Full Text] [Related]
10. Squamous epithelial hyperplasia and carcinoma in mice transgenic for the human papillomavirus type 16 E7 oncogene.
Herber R; Liem A; Pitot H; Lambert PF
J Virol; 1996 Mar; 70(3):1873-81. PubMed ID: 8627712
[TBL] [Abstract][Full Text] [Related]
11. Chronic estrogen-induced cervical and vaginal squamous carcinogenesis in human papillomavirus type 16 transgenic mice.
Arbeit JM; Howley PM; Hanahan D
Proc Natl Acad Sci U S A; 1996 Apr; 93(7):2930-5. PubMed ID: 8610145
[TBL] [Abstract][Full Text] [Related]
12. Expression of AP1 during cellular differentiation determines human papillomavirus E6/E7 expression in stratified epithelial cells.
Kyo S; Klumpp DJ; Inoue M; Kanaya T; Laimins LA
J Gen Virol; 1997 Feb; 78 ( Pt 2)():401-11. PubMed ID: 9018063
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional control of human papillomavirus (HPV) oncogene expression: composition of the HPV type 18 upstream regulatory region.
Butz K; Hoppe-Seyler F
J Virol; 1993 Nov; 67(11):6476-86. PubMed ID: 8411351
[TBL] [Abstract][Full Text] [Related]
14. Differential methylation of E2 binding sites in episomal and integrated HPV 16 genomes in preinvasive and invasive cervical lesions.
Chaiwongkot A; Vinokurova S; Pientong C; Ekalaksananan T; Kongyingyoes B; Kleebkaow P; Chumworathayi B; Patarapadungkit N; Reuschenbach M; von Knebel Doeberitz M
Int J Cancer; 2013 May; 132(9):2087-94. PubMed ID: 23065631
[TBL] [Abstract][Full Text] [Related]
15. Honeybee venom possesses anticancer and antiviral effects by differential inhibition of HPV E6 and E7 expression on cervical cancer cell line.
Kim YW; Chaturvedi PK; Chun SN; Lee YG; Ahn WS
Oncol Rep; 2015 Apr; 33(4):1675-82. PubMed ID: 25633640
[TBL] [Abstract][Full Text] [Related]
16. Immunological responses in human papillomavirus 16 E6/E7-transgenic mice to E7 protein correlate with the presence of skin disease.
Frazer IH; Leippe DM; Dunn LA; Liem A; Tindle RW; Fernando GJ; Phelps WC; Lambert PF
Cancer Res; 1995 Jun; 55(12):2635-9. PubMed ID: 7540107
[TBL] [Abstract][Full Text] [Related]
17. HPV-16 E6/E7 promotes cell migration and invasion in cervical cancer via regulating cadherin switch in vitro and in vivo.
Hu D; Zhou J; Wang F; Shi H; Li Y; Li B
Arch Gynecol Obstet; 2015 Dec; 292(6):1345-54. PubMed ID: 26093522
[TBL] [Abstract][Full Text] [Related]
18. Expression of lymphomagenic oncogenes in T-cell lymphomas of HPV 16 transgenic mice.
Yang JT; Liu CZ; Domer P; Iannaccone P
Cancer Detect Prev; 1998; 22(5):405-15. PubMed ID: 9727621
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of transforming growth factor-beta type II receptor (TGF-betaRII) protein and mRNA expression in cervical cancer.
Diaz-Chavez J; Hernandez-Pando R; Lambert PF; Gariglio P
Mol Cancer; 2008 Jan; 7():3. PubMed ID: 18184435
[TBL] [Abstract][Full Text] [Related]
20. Cooperation of genes in HPV16 E6/E7-dependent cervicovaginal carcinogenesis trackable by endoscopy and independent of exogenous estrogens or carcinogens.
Böttinger P; Schreiber K; Hyjek E; Krausz T; Spiotto MT; Steiner M; Idel C; Booras H; Beck-Engeser G; Riederer J; Willimsky G; Wolf SP; Karrison T; Jensen E; Weichselbaum RR; Nakamura Y; Yew PY; Lambert PF; Kurita T; Kiyotani K; Leisegang M; Schreiber H
Carcinogenesis; 2020 Nov; 41(11):1605-1615. PubMed ID: 32221533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
